...
search icon
grdx-img

Entero Therapeutics, Inc. Share Price

GRDX
NAQ
$3.06
+$0.11
(3.73%)
1D
Industry: Independent Power and Renewable Electricity Producers Sector: Utilities

Entero Therapeutics, Inc. Analyst Forecast

Entero Therapeutics, Inc. Share Price Chart

Entero Therapeutics, Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
85.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.97 L
$5.84 H
$3.06

About Entero Therapeutics, Inc., Common Stock

GridAI Technologies Corp. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom. more

Industry: Independent Power and Renewable Electricity ProducersSector: Utilities

Entero Therapeutics, Inc. Stock Returns

Time FrameGRDXSectorS&P500
1-Week Return5.15%4.38%-1.38%
1-Month Return-22.53%5.6%-1.81%
3-Month Return-16.62%2.05%1.38%
6-Month Return62.94%4.66%5.68%
1-Year Return101.98%13.94%11.74%
3-Year Return-98.6%32.85%65.15%
5-Year Return-100%46.16%73.68%
10-Year Return-100%97.38%260.03%

Entero Therapeutics, Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue571.14K537.40K106.21K29.27K48.95K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.09,"profit":true},{"date":"2022-12-31","value":18.6,"profit":true},{"date":"2023-12-31","value":5.13,"profit":true},{"date":"2024-12-31","value":8.57,"profit":true}]
Gross Profit(571.14K)(537.40K)(106.21K)(29.27K)(48.95K)[{"date":"2020-12-31","value":-57114500,"profit":false},{"date":"2021-12-31","value":-53740000,"profit":false},{"date":"2022-12-31","value":-10620700,"profit":false},{"date":"2023-12-31","value":-2927400,"profit":false},{"date":"2024-12-31","value":-4894600,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses26.43M59.06M12.68M15.77M15.62M[{"date":"2020-12-31","value":44.76,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":21.47,"profit":true},{"date":"2023-12-31","value":26.7,"profit":true},{"date":"2024-12-31","value":26.45,"profit":true}]
Operating Income(26.43M)(59.06M)(12.68M)(15.77M)(15.62M)[{"date":"2020-12-31","value":-2643276800,"profit":false},{"date":"2021-12-31","value":-5905688800,"profit":false},{"date":"2022-12-31","value":-1267806600,"profit":false},{"date":"2023-12-31","value":-1577082700,"profit":false},{"date":"2024-12-31","value":-1562127400,"profit":false}]
Total Non-Operating Income/Expense-508.98K(1.96M)(44.09K)3.13K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-384.9,"profit":false},{"date":"2023-12-31","value":-8.66,"profit":false},{"date":"2024-12-31","value":0.61,"profit":true}]
Pre-Tax Income(32.67M)(58.54M)(14.63M)(15.79M)(15.62M)[{"date":"2020-12-31","value":-3267146600,"profit":false},{"date":"2021-12-31","value":-5853784900,"profit":false},{"date":"2022-12-31","value":-1462964200,"profit":false},{"date":"2023-12-31","value":-1579498300,"profit":false},{"date":"2024-12-31","value":-1561902100,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes----(15.62M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1561902100,"profit":false}]
Income From Continuous Operations-(58.54M)(14.63M)(15.79M)(15.62M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5853784900,"profit":false},{"date":"2022-12-31","value":-1462964200,"profit":false},{"date":"2023-12-31","value":-1579498300,"profit":false},{"date":"2024-12-31","value":-1561902100,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(32.67M)(58.54M)(14.63M)(15.79M)(18.06M)[{"date":"2020-12-31","value":-3267146600,"profit":false},{"date":"2021-12-31","value":-5853784900,"profit":false},{"date":"2022-12-31","value":-1462964200,"profit":false},{"date":"2023-12-31","value":-1579498300,"profit":false},{"date":"2024-12-31","value":-1805933600,"profit":false}]
EPS (Diluted)(1.44)(6.54)(11.11)(258.22)(18.63)[{"date":"2020-12-31","value":-144,"profit":false},{"date":"2021-12-31","value":-654,"profit":false},{"date":"2022-12-31","value":-1111,"profit":false},{"date":"2023-12-31","value":-25822.04,"profit":false},{"date":"2024-12-31","value":-1862.59,"profit":false}]

Entero Therapeutics, Inc. Ratios

Entero Therapeutics, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GRDX
Cash Ratio 0.08
Current Ratio 2.62

Entero Therapeutics, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GRDX
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Entero Therapeutics, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GRDX
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.62

Entero Therapeutics, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GRDX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Entero Therapeutics, Inc. share price today?

Entero Therapeutics, Inc. (GRDX) share price today is $3.06

Can Indians buy Entero Therapeutics, Inc. shares?

Yes, Indians can buy shares of Entero Therapeutics, Inc. (GRDX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GRDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Entero Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Entero Therapeutics, Inc. (GRDX) via the Vested app. You can start investing in Entero Therapeutics, Inc. (GRDX) with a minimum investment of $1.

How to invest in Entero Therapeutics, Inc. shares from India?

You can invest in shares of Entero Therapeutics, Inc. (GRDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in GRDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Entero Therapeutics, Inc. shares
What is Entero Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Entero Therapeutics, Inc. (GRDX) is $5.84. The 52-week low price of Entero Therapeutics, Inc. (GRDX) is $0.97.

What is Entero Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Entero Therapeutics, Inc. (GRDX) is

What is Entero Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Entero Therapeutics, Inc. (GRDX) is 0.00

What is Entero Therapeutics, Inc. dividend yield?

The dividend yield of Entero Therapeutics, Inc. (GRDX) is 0.00%

What is the Market Cap of Entero Therapeutics, Inc.?

The market capitalization of Entero Therapeutics, Inc. (GRDX) is $9.92M

What is Entero Therapeutics, Inc.'s stock symbol?

The stock symbol (or ticker) of Entero Therapeutics, Inc. is GRDX

How Can Investors Use Entero Therapeutics, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Entero Therapeutics, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Entero Therapeutics, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Entero Therapeutics, Inc. shares for Indian investors?

When investing in Entero Therapeutics, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Entero Therapeutics, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Entero Therapeutics, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Entero Therapeutics, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Entero Therapeutics, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top